TipHub

₹12

■ +0 +0.00%

As of 12 Feb 2026 · delayed

BSE Listed

GSM · GSM 0
What does GSM · GSM 0 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).

Ganga Pharmaceuticals Limited (539680)

Volume: 8,000Avg Vol 1W: 14,400Avg Vol 1M: 19,27352W Range:₹9.35₹14.6
BSE www.ayurvedganga.com AI Report
Key Ratios
Checked just now
Market Cap₹7 Cr
Current Price₹12
Previous Close₹12
High / Low (52w)₹14.6 / ₹9.35
Volume8,000
Avg Vol (1W)14,400
Avg Vol (1M)19,273
Stock P/E70.59
Book Value₹14.06
Dividend Yield0%
ROE122.1%
ROA0%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0.17
P/B0.85
Debt / Equity0.2
50 DMA—
200 DMA—
Day change+0.00%
SurveillanceGSM · GSM 0
Price Chart
₹12▼ 17.81% · 1Y
₹15₹1232K
2025-09-03
2026-02-12

20-day avg volume: 18K shares

Pros
  • Healthy return on equity of 122.1%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
  • Stock trades below its book value.
Cons
  • Stock trades at a high P/E of 71.
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
EBITDA₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS0.230.460.460.050.090.10.070.12
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹9 Cr₹9 Cr
Total Liabilities₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr
Equity₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹7 Cr₹7 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹-1 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹-1 Cr
Shareholding
Promoter 50.91% Institutions 0% Public 49.09%
Efficiency & Working Capital
ROCE2.8%
Interest Coverage1.6
Dividend Payout—
Debtor Days126 d
Inventory Days164 d
Payable Days38 d
Cash Conversion Cycle251 d
Working Capital Days290 d
Shareholding Details

As of 2026-03-31

Promoter50.9%
FII0%
DII0%
Institutions0%
Public49.1%
Promoter Pledge0%
No. of Shareholders365
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2022Sept 2022Mar 2023Sept 2023Dec 2023Mar 2024Sept 2024Mar 2025Jun 2025Jul 2025Sept 2025Mar 2026
Promoters66.7%66.7%66.7%66.7%56%56%56%56%50.9%50.9%50.9%50.9%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public33.3%33.3%33.3%33.3%44%44%44%44%49.1%49.1%49.1%49.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders356355356359362363365368367367366365
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Sharma Bharat BShareholding of Promoter and Promoter Group24.6%14,56,585
Srijna SharmaShareholding of Promoter and Promoter Group7.5%4,41,905
Bhavesh Dhirajlal TannaPublic Shareholding6.6%3,91,000
Lenus Finvest Private LimitedPublic Shareholding6.3%3,75,000
Plutus Capital Management LlpPublic Shareholding6.3%3,75,000
Anagh Bharat SharmaShareholding of Promoter and Promoter Group6.1%3,60,000
Brijmohan Sharma HufShareholding of Promoter and Promoter Group5.9%3,49,500
Prakash Dhirajlal TannaPublic Shareholding5.5%3,25,000
Bharat Brijmohan Sharma Huf SharmaShareholding of Promoter and Promoter Group3.2%1,90,000
Niranjan Kumar GoelPublic Shareholding2.4%1,44,000
Usha ShuklaShareholding of Promoter and Promoter Group1.6%95,110
Amit ShuklaShareholding of Promoter and Promoter Group1.3%76,450
Sanjay Dhansukhlal ShahPublic Shareholding1.2%72,000
Akshay Amarnath SharmaPublic Shareholding1.2%72,000
Ankita Amit ShuklaShareholding of Promoter and Promoter Group0.7%40,000
Board of Directors
NameDesignationYear
SANJAY VYANKATESH KULKARNIChairman & Non Executive Dir.2025
BHARAT BRIJMOHAN SHARMAmanaging Director2025
SRIJNA SHARMAE D & Wholetime Director2025
Aman Mukesh Chaudhari.Independent Non Exe. Director2025
Munna Baijnath ChaurasiaIndependent Non Exe. Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10855
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000101
2025000101
2025000101
Substantial Acquisitions (SAST)

1 disclosure(s)

Allotment Of Warrants On Preferential Basis17/07/2025 · —
Company Information
Incorporated1989
ChairmanSANJAY VYANKATESH KULKARNI
AuditorBanka & Banka
Investor Email[email protected]
🌐 www.ayurvedganga.com ↗

📍 Gangatat Dhanvantri Marg, Gopcharpada Virar (E), Palghar, Maharashtra, 401305

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Ace Men Engg Works LimitedBFL Asset Finvest LimitedRGF Capital Markets LimitedRadhagobind Commercial LimitedQuick Heal TechnologiesKapil Raj Finance Ltd.Dynamic Archistructures LimitedMobavenue AI Tech LimitedShivkamal Impex LimitedReal Growth Corporation LimitedInteractive Financial Services Ltd.Hiliks Technologies LimitedAll “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search